Melissa Hollo: Intravenous Iron Shows Better Results Than Oral Iron in Pregnancy
Melissa Hollo, Director of Project Management at hc1 and Licensed Independent Clinical Social Worker, shared Robert Brown’s post on LinkedIn, adding:
”A well-done study in Obstetrics and Gynecology reinforcing what many of us are seeing in practice:
Intravenous ferumoxytol isn’t just an alternative to oral iron in pregnancy, it’s more effective.
This randomized trial shows:
- Significantly greater increases in hemoglobin with IV ferumoxytol vs oral ferrous sulfate
- Meaningful improvements in ferritin and iron indices
- Better correction of anemia by the time of delivery
For a condition as common, and consequential, as iron deficiency anemia in pregnancy, this matters.
We cannot continue to rely on oral iron alone when:
- Absorption is variable
- Tolerability limits adherence
- Time to correction is often too slow for the peripartum window
This is exactly why earlier identification and more effective treatment pathways are critical.
The takeaway is clear:
If we are serious about improving maternal outcomes, IV iron should be considered sooner, not later.
Learn how we’re supporting earlier maternal risk detection.”
Robert Brown, Academic Obstetrician, shared a post on LinkedIn about a recent article by Irogue I Igbinosa, published in Obstetrics and Gynecology։
”IV iron versus oral iron pregnancy anemia.”
Title: Intravenous Ferumoxytol Compared With Oral Ferrous Sulfate for Iron Deficiency Anemia in Pregnancy
A Randomized Controlled Trial
Authors: Irogue I Igbinosa, Stephanie A Leonard, Ijeoma Iwekaogwu, Elizabeth B Sherwin, Caroline Berube, Deirdre J Lyell
Stay updated on all scientific advances with Hemostasis Today.
-
May 13, 2026, 16:01Sifat Jubaira: When Low MCV Meets High Platelets
-
May 13, 2026, 15:58Aktham El-rekaby: Immunothrombosis in Acute Ischaemic Stroke
-
May 13, 2026, 15:49Alison Dougall: Oral Health and Cardiovascular Risk in Bleeding Disorders
-
May 13, 2026, 15:38International Journal of Stroke: Oral Anticoagulants and DOAC–Antiplatelet Therapy Are Associated with Increased Major Bleeding Risk
-
May 13, 2026, 15:19Papa Heme։ Causes of Isolated Prolonged aPTT Without Bleeding
-
May 13, 2026, 15:10Wolfgang Miesbach: Rethinking Bleeding Risk in Anticoagulation
-
May 13, 2026, 15:09Veronica Sanchez: Better Cardiovascular Health Helps Lower Heart Attack Risk
-
May 13, 2026, 15:07Tung Nguyen Thanh: New Perspective on Thrombosis in Hematological Malignancies in Vietnam
-
May 13, 2026, 15:03Haji Siyamuddin Ansari: The Key Difference Between Plasma and Serum